We are live on
!
Find out more
AIM
Arcadia Investment Management Portfolio holdings
AUM
$584M
1-Year Est. Return
21.44%
This Fund
S&P 500
This Quarter
Est. Return
+10.3%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$422M
AUM Growth
+$38.6M
(+10%)
Cap. Flow
+$1.43M
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
28.92%
Holding
117
New
5
Increased
29
Reduced
46
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$2.92M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$1.2M |
| 3 |
Fastenal
FAST
|
+$584K |
| 4 |
Haemonetics
HAE
|
+$428K |
| 5 |
Dick's Sporting Goods
DKS
|
+$278K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$2.01M |
| 2 |
O'Reilly Automotive
ORLY
|
+$468K |
| 3 |
Adobe
ADBE
|
+$221K |
| 4 |
BWLD
Buffalo Wild Wings, Inc.
BWLD
|
+$220K |
| 5 |
ScottsMiracle-Gro
SMG
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.21% |
| 2 | Healthcare | 16.03% |
| 3 | Consumer Discretionary | 15.38% |
| 4 | Industrials | 14.34% |
| 5 | Financials | 10.26% |
Similar funds
MPIA
KI
HA
CGIM
RIS
CM
TAM
GIM
Arcadia Investment Management's Q4 2013 Portfolio in Review
As of Q4 2013, Arcadia Investment Management held 117 positions worth $422M, up 10% from $384M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Arcadia Investment Management's Q4 2013 filing shows 5 new, 29 increased, 46 reduced and 2 closed positions. Its largest new stake was Haemonetics: 10,400 shares worth $438K. The largest sale was Teva Pharmaceuticals, an estimated $2.01M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Arcadia Investment Management's largest Q4 2013 buy was Haemonetics: 10,400 shares worth $438K.
- Arcadia Investment Management added most to Viatris in Q4 2013, an estimated $2.92M increase.
- Arcadia Investment Management's biggest Q4 2013 reduction was O'Reilly Automotive, cutting an estimated $468K.
- Arcadia Investment Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $2.01M.
- Arcadia Investment Management's ten largest holdings make up 29% of its $422M portfolio in Q4 2013.
- Arcadia Investment Management opened 5 new positions and closed 2 in Q4 2013.
- Arcadia Investment Management's portfolio value rose 10% quarter-over-quarter to $422M.
Based on Arcadia Investment Management's 13F filing for Q4 2013, filed 6 Feb 2014.